Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis
Conclusion: Targeted therapy, when associated with conventional CT, demonstrated gains in the PFS of patients with TNBC.Keywords: triple-negative, chemotherapy, breast cancer, systematic review
Source: Core Evidence - Category: Drugs & Pharmacology Tags: Core Evidence Source Type: research
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Drugs & Pharmacology | Erbitux | Study